The European Commission will today sign a contract for 300 million doses of a new Covid-19 vaccine.
The double dose jab, created by Pfizer and BioNTech, has been found to be 90 percent effective in trials.
Commission President Ursula Von Der Leyen says when it becomes available it'll be distributed quickly to member states.
